ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease and rheumatoid arthritis (RA)"

  • Abstract Number: 2360 • 2017 ACR/ARHP Annual Meeting

    A Correlation Study between Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis and Nailfold Videocapillaroscopy

    Tania Adriana Luna-Zúñiga1, Marco Ulises Martinez-Martinez2, Enrique Cuevas-Orta1, Georgina Martínez-Flores1, Georgina Aguilera Barragán-Pickens1, Angel Javier Pedro Martínez1, Dolores Ramos-Bello3, Homero López-Ferretis1, David Herrera Van Oostdam4 and Carlos Abud-Mendoza5, 1Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 2Unidad de Investigaciones Reumatológicas, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico, 3Reumatología, Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosi, Mexico, 4Unidad de Investigaciones Reumatológicas, Hospital Central & Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico, 5Unidad de Investigaciones Reumatológicas y Osteoporosis, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico

    Background/Purpose: The most common cause of mortality in RA patients is the cardiovascular disease (CVD), with almost twice the risk for CVD events. Nailfold videocapillaroscopy…
  • Abstract Number: 2364 • 2017 ACR/ARHP Annual Meeting

    Decrease in Cardiovascular Event Excess Risk in Rheumatoid Arthritis Since 2000: A Meta- Analysis of Controlled Studies

    Elisabeth Filhol1, Charlotte Hua2, Anaiz Nutz3, Françoise Flaisler1, Cédric Lukas4, Jacques Morel5, Bernard Combe5 and Cécile Gaujoux-Viala6, 1Rheumatology, Nîmes University Hospital, Nîmes, France, 2Reumatology, CHU Lapeyronie and Montpellier University, Montpellier, France, 3Rheumatology, Nîmes University Hospital and Montpellier University, Nîmes, France, 4Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 5Rheumatology, CHU Lapeyronie and Montpellier University, Montpellier, France, 6Rheumatology, Nîmes University Hospital and EA2415 Montpellier University, Nîmes, France

    Background/Purpose: Compared with the general population, patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease or events (CE): stroke, Myocardial Infarction (MI),…
  • Abstract Number: 2368 • 2017 ACR/ARHP Annual Meeting

    Global Circumferential Strain By Assessed a Feature Tracking Cardiac Magnetic Resonance (CMR) Imaging  Was Associated with Myocardial Fibrosis in RA Patients

    Yasuyuki Kobayashi1, Hitomi Kobayashi2, Isamu Yokoe3, Atsuma Nishiwaki4, Akiyuki Kotoku5 and Masami Takei4, 1Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 2Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 3Rheumatology, Kyoundo Hospital, Sasaki Institute, Tokyo, Japan, 4Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 5Advanced Biomedical Imaging Informatics, St. Marianna University School of Medicine, Kawasaki, Japan

    Background/Purpose: Individuals with RA have a 1.5-2.0 fold higher risk of developing congestive heart failure (CHF) than the general population. It is important to understand…
  • Abstract Number: 423 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk and Lipid Screening in Rheumatoid Arthritis Patients in a University Rheumatology Practice: Quality Improvement Project

    Diana Mosteanu, Xuan Wang, Donald Kimpel and Janet Lewis, University of Virginia, Charlottesville, VA

    Background/Purpose: Meta-analyses of observational studies showed that RA patients’ morbidity and mortality risks stemming from cardiovascular (CV) causes were, respectively, close to 50% and 60%…
  • Abstract Number: 1465 • 2016 ACR/ARHP Annual Meeting

    Utility of Relative Cardiovascular Risk Score Scales in Patients UNDER the Age of 50 and Its Association with the Presence of Carotid Atherosclerosis in the Ultrasound

    Andrea Zacarias1, Carmen Gomez Vaquero2, Francisco Javier Narváez3, Miguel Angel González-Gay4, Alfonso Corrales5, Carlos González-Juanatey6, Javier Llorca7 and Joan Miquel Nolla8, 1Hospital Universitari de Bellvitge, Barcelona, Spain, 2Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 3Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain, 5Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 6Cardiology Division, Hospital Xeral-Calde, Lugo, Spain, 7Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 8Rheumatology, Bellvitge University Hospital, Barcelona, Spain

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with a greater cardiovascular mortality than the general population of the same age and gender. Cardiovascular events prediction scales,…
  • Abstract Number: 1466 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease

    Erin Scanlon1, Rekha Mankad2, Cynthia S. Crowson3, Iftikhar Kullo4, Sharon Mulvagh2, Eric L. Matteson1, Zoran Kvrgic1 and John M. Davis III5, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:  Persons with rheumatoid arthritis (RA) have increased morbidity and mortality attributable to atherosclerotic cardiovascular disease (ASCVD) events. It is unknown how presence of subclinical…
  • Abstract Number: 1472 • 2016 ACR/ARHP Annual Meeting

    Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis

    Lucia C. Domínguez-Casas1, Leyre Riancho-Zarrabeitia1, Nuria Vegas-Revenga2, Alfonso Corrales1, Carlos Fernández Díaz1, Montserrat Santos-Gómez3, Virginia Portilla2, Patrick H Dessein4, Ricardo Blanco1 and Miguel Angel Gonzalez-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 3Rheumatology, Hospital Can Misses, Ibiza, Spain, 4Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose:   Carotid plaque (CP) detected by ultrasonography and carotid intima-media thickness (cIMT) are useful surrogate markers for subclinical atherosclerosis and good predictors of cardiovascular…
  • Abstract Number: 1476 • 2016 ACR/ARHP Annual Meeting

    Diastolic Dysfunction in Patients with Rheumatoid Arthritis: Predictors of Longitudinal Progression over Five Years

    John M. Davis III1, Grace Lin2, Jae Oh3, Sara J. Achenbach4, Terry M. Therneau5, Eric L. Matteson6, Elena Myasoedova6, Sherine E. Gabriel7 and Cynthia S. Crowson8, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2General Internal Medicine, University of California San Francisco, San Francisco, CA, 3ICON Late Phase and Outcomes Research, San Francisco, CA, 4Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 5Biostatistics, Mayo Clinic, Rochester, MN, 6Rheumatology, Mayo Clinic, Rochester, MN, 7Dean's Office, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 8Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose:   The impairment of left ventricular (LV) relaxation and passive filling, known as diastolic dysfunction, undergirds the development of heart failure in patients with…
  • Abstract Number: 1491 • 2016 ACR/ARHP Annual Meeting

    M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients

    Ida G. Louw1, Christian G. Ammitzböll2, Brian Bridal Løgstrup3, Jesper Blegvad-Nissen4, Grazina Urbonaviciene4, Trine Bay Laurberg4, Mette Herly5, Agnete H. Nielsen4, Steffen Thiel6 and Torkell Ellingsen5, 1University of Southern Denmark, Odense, DK, Odense, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 3Department of Cardiology, Skejby, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 4Diagnostic Centre, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, DK, Silkeborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, DK, Odense, Denmark, 6Institute of Biomedicine, Aarhus University, Aarhus, DK, Aarhus, Denmark

    Background/Purpose:  79 DMARD-naïve RA patients with a disease duration < 6 months were included from an inception cohort. Clinical variables, plasma- and serum-M-ficolin and MAp44…
  • Abstract Number: 1990 • 2016 ACR/ARHP Annual Meeting

    Increased Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis over a 15 Year Time Period That Is Comparable to Type 2 Diabetes

    Rabia Agca1,2, Luuk H.G.A. Hopman2, Vokko P. van Halm3, Mike J.L. Peters4, Jacqueline M. Dekker5, Giel Nijpels5, Coen D.A. Stehouwer6, Yvo M. Smulders4, Alexandre E. Voskuyl1, Maarten Boers1, Willem F. Lems7 and Mike T. Nurmohamed2,8, 1Rheumatology, Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center, Location Reade, Amsterdam, Netherlands, 3Cardiology, VU University Medical Center, Amsterdam, Netherlands, 4Internal Medicine, VU University Medical Center, Amsterdam, Netherlands, 5EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 6Internal Medicine, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands, 7Rheumatology, Amsterdam Rheumatology and immunology Center, location VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 8Rheumatology, Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands

    Background/Purpose:  recent cohort studies with long term follow up studying this risk are scarce.We report the results of a 15 year observational cohort study comparing…
  • Abstract Number: 1548 • 2015 ACR/ARHP Annual Meeting

    Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort

    Alberto Cardenas-de La Garza1, Raymundo Vera-Pineda2, Dionicio A. Galarza-Delgado1, Jose Ramon Azpiri-Lopez3, Iris J. Colunga-Pedraza1, Griselda Serna-Peña4 and Mario Alberto Garza-Elizondo1, 1Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 2Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 3Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 4Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico

    Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in RA. Management and stratification of ASCVD in RA patients is still a matter…
  • Abstract Number: 3257 • 2015 ACR/ARHP Annual Meeting

    The Link Between DAS28 and the Short-Term Risk of Acute Coronary Syndrome in RA, and Its Driving Factors

    Lotta Ljung1,2, Thomas Frisell3 and Johan Askling3,4, 1Department of Medicine, Solna, Clinical epidemiology unit, Karolinska Institutet, Stockholm, Sweden, 2Department for Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 3Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology Unit, Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: The extent to which a short-term effect of the disease activity adds to the over-risk of coronary events in patients with Rheumatoid Arthritis (RA)…
  • Abstract Number: 1565 • 2015 ACR/ARHP Annual Meeting

    High Disease Activity over Time and Persistent Inflammation Are Associated with Increased Risk of Cardiovascular Disease in Patients with Early Rheumatoid Arthritis

    Emil Rydell1,2, Christina Book1,2, Jan-Åke Nilsson1,2, Minna Willim1,2, Lennart T.H. Jacobsson1,3 and Carl Turesson1,4, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 3Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, 4Lund University, Rheumatology, Dept. of Clinical Sciences,, Malmö, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased rate of cardiovascular (CV) disease. Systemic inflammation has been implicated as a key factor behind CV…
  • Abstract Number: 1572 • 2015 ACR/ARHP Annual Meeting

    Plasma Apolipoprotein B48 Levels in Patients with Rheumatoid Arthritis: Evaluating Novel Cardiovascular Risk Factors

    Deborah van Breukelen-van der Stoep1, Derkjen van Zeben1, Marijke de Vries2, Boudewijn Klop2, Noelle van der Meulen2, Gert Jan van de Geijn3, Hans Janssen3, Pedro Valdivielso4, José Rioja4, José Ramirez-Bollero4, Mieke Hazes5, Erwin Birnie6,7 and Manuel Castro Cabezas8, 1Department of Rheumatology, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 2Department of Internal Medicine, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 3Department of Clinical Chemistry, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 4Department of Internal Medicine and Dermatology, Hospital Virgen de la Victoria, Malaga, Spain, 5Department of Rheumatology, Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands, 6Statistics and Education, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 7Insitute of Health Policy and Management, Erasmus University, Rotterdam, Netherlands, 8Department of Internal Medicine, Sint Francicscus Gasthuis, Rotterdam, Netherlands

    Background/Purpose: Chylomicrons, with apolipoprotein (apo) B48 as a structural protein, induce leukocyte and complement activation and contribute to atherosclerosis. ApoB48 is higher in conditions associated…
  • Abstract Number: 1575 • 2015 ACR/ARHP Annual Meeting

    Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis

    Ruth Davies1, Daniela Iacono2, Lauren A. Jordan1, Jessica O Williams1, Charlotte Rawlings1, Derek Lang3, Anwen S. Williams1 and Ernest H. Choy1, 1Cardiff University, Institute of Infection and Immunity, Tenovus Building, University Hospital of Wales, Cardiff, United Kingdom, 2Department of Clinical and Experimental Medicine. Rheumatology Section. Second University of Naples, Naples, Italy, 3Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom

    Background/Purpose:  Mortality is increased in Rheumatoid arthritis (RA) patients mainly due to cardiovascular (CV) disease; however the biologic mechanisms are unknown. Increased CV risk in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology